The effect of Coix lachrymal L. seed extract on the expression of inflammation and fibrogenesis genes in human retinal pigment epithelial cells
View abstract on PubMed
Summary
This summary is machine-generated.Adlay seed extract fractions show promise in treating proliferative vitreoretinopathy (PVR). The residual fraction, rich in bioactive compounds, effectively reduced PVR-associated pathways in retinal cells.
Area Of Science
- Ophthalmology
- Pharmacology
- Cell Biology
Background
- Proliferative vitreoretinopathy (PVR) is a major cause of vision loss following retinal detachment, driven by fibrocellular scar formation.
- Current treatments for PVR are limited, necessitating the exploration of novel therapeutic agents.
- Retinal pigment epithelial (RPE) cells play a critical role in PVR pathogenesis through proliferation, inflammation, and fibrogenesis.
Purpose Of The Study
- To investigate the therapeutic potential of adlay seed extract fractions (methanolic and residual) in mitigating PVR-associated pathways.
- To evaluate the effects of adlay fractions on oxidative stress, proliferation, inflammation, and fibrogenesis in RPE cells.
- To characterize the biochemical composition and antioxidant activity of adlay seed extract fractions.
Main Methods
- Adlay seed extract fractions (MeOH and Res) were prepared and analyzed for bioactive compounds and antioxidant capacity.
- RPE cell viability was assessed using the MTT assay after treatment with adlay fractions.
- Gene expression of key PVR-related markers (IL-1β, IL-6, LIF, TGF-β, Snail, α-SMA) was analyzed using real-time PCR.
Main Results
- The residual (Res) adlay fraction demonstrated higher protein, carbohydrate, flavonoid, and phenol content, along with superior antioxidant activity compared to the methanolic (MeOH) fraction.
- Both adlay fractions inhibited RPE cell viability, with the Res fraction showing a more significant effect.
- The MeOH fraction reduced IL-6 and TGF-β gene expression, while the Res fraction significantly decreased IL-6, LIF, TGF-β, Snail, and α-SMA expression.
Conclusions
- Adlay seed extract fractions possess therapeutic potential for PVR by modulating key pathogenic pathways in RPE cells.
- The Res fraction, due to its rich bioactive profile and potent antioxidant activity, is particularly promising for attenuating oxidative stress, proliferation, inflammation, and fibrogenesis.
- Adlay seed extracts represent a potential novel therapeutic strategy for PVR, warranting further preclinical and clinical investigation.

